Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies

Fontanarosa, Phil B.; Flanagin, Annette; DeAngelis, Catherine D.

doi:10.1001/jama.294.1.110

Cited by 126 publications

(107 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With increased media attention and public scrutiny of reported conflicts, and concerns about the impact of industry-sponsorship, journals have stressed the importance of such author disclosures, and in many cases have attempted to make them mandatory. 1,2 Previous studies have focused primarily on the impact that study funding and author COI have on the reporting and conclusions of journal articles. [3][4][5][6][7][8][9][10][11] Conflicts of interest among journal peer-reviewers and editors may be equally important, however, as these groups control decisions about article publication and publication content, and thus have enormous impact on the biomedical literature.…”

mentioning

confidence: 99%

Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals

et al. 2006

View full text Add to dashboard Cite

OBJECTIVE:We undertook this investigation to characterize conflict of interest (COI) policies of biomedical journals with respect to authors, peer-reviewers, and editors, and to ascertain what information about COI disclosures is publicly available. METHODS:We performed a cross-sectional survey of a convenience sample of 135 editors of peer-reviewed biomedical journals that publish original research. We chose an international selection of general and specialty medical journals that publish in English. Selection was based on journal impact factor, and the recommendations of experts in the field. We developed and pilot tested a 3-part web-based survey. The survey included questions about the presence of specific policies for authors, peer-reviewers, and editors, specific restrictions on authors, peer-reviewers, and editors based on COI, and the public availability of these disclosures. Editors were contacted a minimum of 3 times. RESULTS:The response rate for the survey was 91 (67%) of 135, and 85 (93%) of 91 journals reported having an author COI policy. Ten (11%) journals reported that they restrict author submissions based on COI (e.g., drug company authors' papers on their products are not accepted). While 77% report collecting COI information on all author submissions, only 57% publish all author disclosures. A minority of journals report having a specific policy on peer-reviewer 46% (42/91) or editor COI 40% (36/91); among these, 25% and 31% of journals state that they require recusal of peer-reviewers and editors if they report a COI. Only 3% of respondents publish COI disclosures of peer-reviewers, and 12% publish editor COI disclosures, while 11% and 24%, respectively, reported that this information is available upon request.CONCLUSION: Many more journals have a policy regarding COI for authors than they do for peer-reviewers or editors. Even author COI policies are variable, depending on the type of manuscript submitted. The COI information that is collected by journals is often not published; the extent to which such ''secret disclosure'' may impact the integrity of the journal or the published work is not known.

show abstract

mentioning

confidence: 99%

Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Research is becoming progressively complex and quality standards increasingly demanding [17][18][19][20][21][22][23][24] . As a result, conducting clinical studies is becoming more expensive and the role of sponsors to ensure the viability of research projects is becoming critical.…”

Section: Discussionmentioning

confidence: 99%

“…As a result, conducting clinical studies is becoming more expensive and the role of sponsors to ensure the viability of research projects is becoming critical. However, funding from different sources may directly affect investigators and COI may inappropriately influence their actions or judgement [17][18][19][20][21][22][23][24] . Subtle biases in design and interpretation may arise when a sponsor stands to gain from the report 17 .…”

Section: Discussionmentioning

confidence: 99%

“…Pharmaceutical and technological companies are responsible for most important advancements in medical knowledge [17][18][19][20][21][22][23][24] . Patients, doctors and society as a whole benefit from this unique effort and should be grateful for the research commitment by the industry.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, it is easy to understand the extra scrutiny of industrysponsored research by reviewers and editors 33 . Some editors require that authors of industry-associated research have their data analysis confirmed by a different source and others even ask for the raw data to be analysed by an independent academic statistician 20,33 . Some editors do not commission editorial or review articles from authors with potential COI as these may blur objectivity 19,44,45 .…”

Section: Additional Editorial Perspectives Regarding Conflicts Of Intmentioning

confidence: 99%

See 2 more Smart Citations

Políticas de conflito de interesses e exigências para divulgação em Revistas Científicas de Cardiologia Nacionais da Sociedade Europeia de Cardiologia

Alfonso¹,

Pinto²,

Ambrosio³

et al. 2012

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Disclosure of potential conflicts of interest (COI) is used by biomedical journals to guarantee credibility and transparency of the scientific process. COI disclosure, however, is not systematically nor consistently dealt with by journals. Recent joint editorial efforts paved the way towards the implementation of uniform vehicles for COI disclosure. This paper provides a comprehensive editorial perspective on classical COI-related issues. New insights into current COI policies and practices among European Society of Cardiology national cardiovascular journals, as derived from a cross-sectional survey using a standardised questionnaire, are discussed.

show abstract

Publication of Clinical Trials in JAMA

Fontanarosa¹,

DeAngelis²

2008

JAMA

View full text Add to dashboard Cite

Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies

Cited by 126 publications

References 8 publications

Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals

Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals

Políticas de conflito de interesses e exigências para divulgação em Revistas Científicas de Cardiologia Nacionais da Sociedade Europeia de Cardiologia

Publication of Clinical Trials in JAMA

Contact Info

Product

Resources

About